Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
15.18 EUR | +1.07% |
|
-5.01% | -8.66% |
Feb. 10 | Medincell: a milestone payment from Teva | CF |
Feb. 10 | Medincell: a milestone payment from Teva | CF |
EPS & Dividend: MedinCell S.A.
Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Dividend per Share 2 | - | - | - | - | - | - | - | - |
Rate of return | - | - | - | - | - | - | - | - |
EPS 2 | -1.19 | -0.86 | -1 | -1.27 | -0.88 | -0.65 | 0.42 | 1.53 |
Distribution rate | - | - | - | - | - | - | - | - |
Reference price 2 | 5.96 | 11.70 | 7.42 | 9.81 | 9.59 | 15.02 | 15.02 | 15.02 |
Nbr of stocks (in thousands) | 20,097 | 24,581 | 25,121 | 25,101 | 28,749 | 29,229 | - | - |
Announcement Date | 6/4/20 | 6/16/21 | 6/14/22 | 6/26/23 | 6/10/24 | - | - | - |
Upcoming events: MedinCell S.A.
Yield (N) | Yield (N+1) | P/E ratio (N) | Price to Book (N) | EV / Sales (N) | ||
---|---|---|---|---|---|---|
-.--% | -.--% | -23.11x | -8.84x | 22.44x | ||
0.6% | 0.68% | 70.58x | 46.64x | 17.84x | ||
2.25% | 2.73% | 22.44x | 13.27x | 7.93x | ||
3.09% | 3.27% | 22.27x | 5.21x | 4.31x | ||
3.27% | 3.44% | 43.21x | 46.5x | 7.05x | ||
3.42% | 3.49% | 15.4x | 5.9x | 3.76x | ||
2.14% | 2.22% | 27.23x | 5.45x | 4.64x | ||
3.57% | 3.77% | 16.62x | 4.66x | 4.18x | ||
3.06% | 3.26% | 32.28x | 24.37x | 6.26x | ||
6.44% | 6.57% | 15.2x | 1.65x | 3.25x | ||
Average | percentage-no-prefix | percentage-no-prefix | 24.21x | 14.48x | 8.17x | |
Weighted average by Cap. | percentage-no-prefix | percentage-no-prefix | 37.49x | 23.35x | 8.83x |